Format

Send to

Choose Destination
Science. 1998 Apr 17;280(5362):438-40.

Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.

Author information

1
Department of Medical Pathology, University of California, Davis, CA 95616, USA. nbalaban@ucdavis.edu

Abstract

Staphylococcus aureus causes pathologies ranging from minor skin infections to life-threatening diseases. Pathogenic effects are largely due to production of bacterial toxin, which is regulated by an RNA molecule, RNAIII. The S. aureus protein called RAP (RNAIII activating protein) activates RNAIII, and a peptide called RIP (RNAIII inhibiting peptide), produced by a nonpathogenic bacteria, inhibits RNAIII. Mice vaccinated with RAP or treated with purified or synthetic RIP were protected from S. aureus pathology. Thus, these two molecules may provide useful approaches for the prevention and treatment of diseases caused by S. aureus.

Comment in

PMID:
9545222
DOI:
10.1126/science.280.5362.438
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center